JPY 1428.0
(1.35%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 5.8 Billion JPY | 8.13% |
2022 | 5.36 Billion JPY | 9.66% |
2021 | 4.89 Billion JPY | -4.36% |
2020 | 5.11 Billion JPY | 26.46% |
2019 | 4.04 Billion JPY | 12.77% |
2018 | 3.58 Billion JPY | 15.81% |
2017 | 3.09 Billion JPY | 16.26% |
2016 | 2.66 Billion JPY | 17.22% |
2015 | 2.27 Billion JPY | 9.57% |
2014 | 2.07 Billion JPY | 12.01% |
2013 | 1.85 Billion JPY | 15.76% |
2012 | 1.59 Billion JPY | 19.94% |
2011 | 1.33 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.68 Billion JPY | 13.39% |
2023 FY | 5.8 Billion JPY | 8.13% |
2023 Q3 | 1.45 Billion JPY | 2.63% |
2023 Q1 | 1.44 Billion JPY | 8.9% |
2023 Q2 | 1.41 Billion JPY | -1.7% |
2023 Q4 | 1.48 Billion JPY | 1.74% |
2022 Q4 | 1.32 Billion JPY | -0.5% |
2022 FY | 5.36 Billion JPY | 9.66% |
2022 Q3 | 1.33 Billion JPY | -2.87% |
2022 Q2 | 1.37 Billion JPY | 2.75% |
2022 Q1 | 1.33 Billion JPY | 12.42% |
2021 FY | 4.89 Billion JPY | -4.36% |
2021 Q2 | 1.28 Billion JPY | 8.25% |
2021 Q4 | 1.18 Billion JPY | -3.2% |
2021 Q1 | 1.18 Billion JPY | -19.91% |
2021 Q3 | 1.22 Billion JPY | -4.77% |
2020 Q1 | 1.03 Billion JPY | 11.03% |
2020 Q2 | 1.28 Billion JPY | 24.56% |
2020 FY | 5.11 Billion JPY | 26.46% |
2020 Q3 | 1.3 Billion JPY | 1.31% |
2020 Q4 | 1.48 Billion JPY | 13.76% |
2019 Q1 | 1.02 Billion JPY | 14.77% |
2019 FY | 4.04 Billion JPY | 12.77% |
2019 Q2 | 1.08 Billion JPY | 5.48% |
2019 Q4 | 932.01 Million JPY | -6.82% |
2019 Q3 | 1 Billion JPY | -7.76% |
2018 Q4 | 895.81 Million JPY | -1.81% |
2018 Q2 | 912.62 Million JPY | 5.37% |
2018 Q1 | 866.11 Million JPY | 4.28% |
2018 FY | 3.58 Billion JPY | 15.81% |
2018 Q3 | 912.32 Million JPY | -0.03% |
2017 Q3 | 754.46 Million JPY | -2.34% |
2017 FY | 3.09 Billion JPY | 16.26% |
2017 Q1 | 739.64 Million JPY | 0.56% |
2017 Q4 | 830.59 Million JPY | 10.09% |
2017 Q2 | 772.5 Million JPY | 4.44% |
2016 Q4 | 735.54 Million JPY | 11.8% |
2016 FY | 2.66 Billion JPY | 17.22% |
2016 Q3 | 657.92 Million JPY | 5.35% |
2016 Q2 | 624.53 Million JPY | -3.32% |
2016 Q1 | 645.99 Million JPY | 18.56% |
2015 Q2 | 563.47 Million JPY | -3.16% |
2015 Q4 | 544.86 Million JPY | -6.46% |
2015 Q3 | 582.48 Million JPY | 3.37% |
2015 FY | 2.27 Billion JPY | 9.57% |
2015 Q1 | 581.83 Million JPY | 4.62% |
2014 FY | 2.07 Billion JPY | 12.01% |
2014 Q4 | 556.13 Million JPY | 13.0% |
2014 Q3 | 492.14 Million JPY | 0.17% |
2014 Q2 | 491.28 Million JPY | -8.1% |
2014 Q1 | 534.6 Million JPY | 20.2% |
2013 Q1 | 493.68 Million JPY | 13.61% |
2013 Q3 | 435.73 Million JPY | -8.77% |
2013 Q4 | 444.77 Million JPY | 2.08% |
2013 FY | 1.85 Billion JPY | 15.76% |
2013 Q2 | 477.64 Million JPY | -3.25% |
2012 FY | 1.59 Billion JPY | 19.94% |
2012 Q2 | 393 Million JPY | 0.0% |
2012 Q3 | 362 Million JPY | -7.89% |
2012 Q4 | 434.56 Million JPY | 20.05% |
2011 FY | 1.33 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Kitanotatsujin Corporation | 9.38 Billion JPY | 38.184% |
Euglena Co., Ltd. | 34.45 Billion JPY | 83.164% |
Axas Holdings Co.,Ltd. | 3 Billion JPY | -93.314% |
C.I. Medical Co.,Ltd. | 9 Billion JPY | 35.596% |
Kao Corporation | 438.95 Billion JPY | 98.679% |
Niitaka Co., Ltd. | 6.65 Billion JPY | 12.906% |
Rohto Pharmaceutical Co.,Ltd. | 117.23 Billion JPY | 95.053% |
Shiseido Company, Limited | 696.62 Billion JPY | 99.167% |
Lion Corporation | 160.09 Billion JPY | 96.377% |
Mandom Corporation | 29.51 Billion JPY | 80.345% |
Ivy Cosmetics Corporation | 1.72 Billion JPY | -236.174% |
Milbon Co., Ltd. | 24 Billion JPY | 75.832% |
Nippon Shikizai, Inc. | 2.31 Billion JPY | -150.902% |
Fancl Corporation | 61.61 Billion JPY | 90.587% |
KOSÉ Corporation | 189.85 Billion JPY | 96.945% |
Cota Co., Ltd. | 4.25 Billion JPY | -36.376% |
HABA Laboratories,Inc. | 8.21 Billion JPY | 29.384% |
C'bon Cosmetics Co.,Ltd. | 6.37 Billion JPY | 8.952% |
Pola Orbis Holdings Inc. | 119.68 Billion JPY | 95.154% |
Noevir Holdings Co., Ltd. | 31.54 Billion JPY | 81.61% |
Adjuvant Holdings Co.,Ltd. | 2.86 Billion JPY | -102.69% |
Almado, Inc. | 4.11 Billion JPY | -41.108% |
I-ne CO., LTD. | 17.86 Billion JPY | 67.533% |
Premier Anti-Aging Co., Ltd. | 15.96 Billion JPY | 63.66% |
Liberta Co.,Ltd. | 2.68 Billion JPY | -116.337% |
AXXZIA Inc. | 8.57 Billion JPY | 32.338% |
S.T. Corporation | 15.07 Billion JPY | 61.519% |
Kobayashi Pharmaceutical Co., Ltd. | 70.59 Billion JPY | 91.784% |
Earth Corporation | 57.25 Billion JPY | 89.869% |
Sagami Rubber Industries Co., Ltd. | 1.57 Billion JPY | -269.267% |
Asahi Eito Holdings Co.,Ltd. | 1.29 Billion JPY | -346.702% |
Ya-Man Ltd. | 18.49 Billion JPY | 68.644% |
MTG Co., Ltd. | 33.26 Billion JPY | 82.562% |
TRANSACTION CO.,Ltd. | 4.57 Billion JPY | -26.741% |
SHOBIDO Corporation | 4.5 Billion JPY | -28.884% |
Artnature Inc. | 25.01 Billion JPY | 76.813% |
Pigeon Corporation | 34.72 Billion JPY | 83.298% |
Unicharm Corporation | 351.52 Billion JPY | 98.35% |
Paltac Corporation | 53.06 Billion JPY | 89.069% |
CB GROUP MANAGEMENT Co., Ltd. | 13.78 Billion JPY | 57.923% |